Does the molecular subtype of breast cancer influence your decision to give hypofractionated radiotherapy?  

Should hypofractionation be avoided in triple negative disease?



Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Academic Institution